145 related articles for article (PubMed ID: 6070)
21. Purification of L-asparaginase from a bacteria Erwinia carotovora and effect of a dihydropyrimidine derivative on some of its kinetic parameters.
Kamble VP; Rao RS; Borkar PS; Khobragade CN; Dawane BS
Indian J Biochem Biophys; 2006 Dec; 43(6):391-4. PubMed ID: 17285805
[TBL] [Abstract][Full Text] [Related]
22. Comparative experimental evaluation of immunodepressive and toxic effects of L-asparaginase (NSC-109229) from Escherichia coli and from Erwinia carotovora.
Cavanna M; Celle G; Dodero M; Picciotto A; Pannacciulli I; Brambilla G
Cancer Treat Rep; 1976 Mar; 60(3):255-7. PubMed ID: 769978
[No Abstract] [Full Text] [Related]
23. Reduction in immunogenicity and clearance rate of Escherichia coli L-asparaginase by modification with monomethoxypolyethylene glycol.
Kamisaki Y; Wada H; Yagura T; Matsushima A; Inada Y
J Pharmacol Exp Ther; 1981 Feb; 216(2):410-4. PubMed ID: 7007618
[TBL] [Abstract][Full Text] [Related]
24. Structure of the isoaspartyl peptidase with L-asparaginase activity from Escherichia coli.
Prahl A; Pazgier M; Hejazi M; Lockau W; Lubkowski J
Acta Crystallogr D Biol Crystallogr; 2004 Jun; 60(Pt 6):1173-6. PubMed ID: 15159592
[TBL] [Abstract][Full Text] [Related]
25. [Effect of different pH values on the activity and quaternary structure of asparaginase in Escherichia coli extracts].
Maksimov VI; Molodova GA; Bespalova TI; Denisov VM
Prikl Biokhim Mikrobiol; 1975; 11(4):539-45. PubMed ID: 1737
[TBL] [Abstract][Full Text] [Related]
26. [Determination of the transferase activity of L-asparaginase].
Buka MR; Zhagat RA; Kirstukas IP; Chepuka LY
Vopr Med Khim; 1975; 21(5):548-52. PubMed ID: 3024
[TBL] [Abstract][Full Text] [Related]
27. [Immobilization of Citrobacter L-asparaginase in polyacrylamide gel].
Galaev IuV; Chuplygina EG; Klement'eva TA
Vopr Med Khim; 1981; 27(4):534-7. PubMed ID: 7293086
[TBL] [Abstract][Full Text] [Related]
28. Purification and properties of L-asparaginase EC-2 from Escherichia coli 055:B5.
Pajdak E; Szafran Z
Acta Biochim Pol; 1977; 24(1):53-8. PubMed ID: 17256
[TBL] [Abstract][Full Text] [Related]
29. Physical properties and subunit structure of L-asparaginase isolated from Erwinia carotovora.
Cammack KA; Marlborough DI; Miller DS
Biochem J; 1972 Jan; 126(2):361-79. PubMed ID: 4561025
[TBL] [Abstract][Full Text] [Related]
30. [Antigenic properties of 1-asparaginases isolated from different species and strains of bacteria].
Chaĭkovskaia SM; Makarova RA; Tochenaia NP; Frolova MA
Antibiotiki; 1976 Mar; 21(3):255-8. PubMed ID: 776078
[TBL] [Abstract][Full Text] [Related]
31. Asparaginase: molecular and enzymic requirements for use as an antileukaemia agent.
Wade HE
J Gen Microbiol; 1971 Mar; 65(3):x-xi. PubMed ID: 4997395
[No Abstract] [Full Text] [Related]
32. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
Boos J
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
[TBL] [Abstract][Full Text] [Related]
33. Transport of L-asparagine in Tetrahymena pyriformis ecto-L-asparaginase is not related to L-asparagine-protein transport system.
Tsavdaridis IK; Triantafillou DJ; Kyriakidis DA
Biochem Int; 1991 May; 24(2):281-90. PubMed ID: 1930247
[TBL] [Abstract][Full Text] [Related]
34. [Sulfhydryl groups of L-asparaginase A from Pseudomonas fluorescens AG].
Sokolov NN; Nikolaev AIa
Biokhimiia; 1976 Apr; 41(4):727-31. PubMed ID: 14736
[TBL] [Abstract][Full Text] [Related]
35. Microcalorimetric determination of substrate specificity of L-asparaginase in Escherichia coli and Erwinia carotovora.
Rekharsky MV; Egorov AM; Bankovskaya SA; Ozoliņa RK; Vĩna IA; Berziņa-Berzĩte RV; Lopatnev SV; Galchenko GL
J Biochem Biophys Methods; 1988 Aug; 16(4):319-21. PubMed ID: 3065395
[No Abstract] [Full Text] [Related]
36. The effect of freeze-drying on the quaternary structure of L-asparaginase from Erwinia carotovora.
Hellman K; Miller DS; Cammack KA
Biochim Biophys Acta; 1983 Dec; 749(2):133-42. PubMed ID: 6652094
[TBL] [Abstract][Full Text] [Related]
37. Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.
Yoshimoto T; Nishimura H; Saito Y; Sakurai K; Kamisaki Y; Wada H; Sako M; Tsujino G; Inada Y
Jpn J Cancer Res; 1986 Dec; 77(12):1264-70. PubMed ID: 3102431
[TBL] [Abstract][Full Text] [Related]
38. Immunological and pharmacological characterization of poly-DL-alanyl-modified Erwinia carotovora L-asparaginase.
Uren JR; Hargis BJ; Beardsley P
Cancer Res; 1982 Oct; 42(10):4068-71. PubMed ID: 7105004
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different techniques for isoelectric focusing on polyacrylamide gel slabs using bacterial asparaginases.
Robinson HK
Anal Biochem; 1972 Oct; 49(2):353-66. PubMed ID: 4563222
[No Abstract] [Full Text] [Related]
40. [Asparagine metabolism in mycobacteria. II. -- Asparagine hydrolysis and aspartohydroxamic acid formation and hydrolysis catalysed by M. fortuitum, M. phlei and BCG asparaginases (author's transl)].
Andrejew A; Orfanelli MT; Desbordes J
Ann Microbiol (Paris); 1975; 126(2):151-60. PubMed ID: 239619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
